Diabetes is associated with a plethora of metabolic changes which may underlie the propensity to development of stroke (Figure 1). 1 Insulin resistance has multiple drivers, is inextricably linked to type 2 diabetes, and is associated with coronary artery 2 and cerebrovascular 3 atherosclerosis. Insulin resistance is mediated by increased levels of bioactive lipids, including ceramides 4 and diacylglycerol, 5 playing a role in cell death in numerous tissues. 6 Hyperglycemia leads to formation of advanced glycation end products and to activation of the polyol pathway, protein kinase C pathway, and the polyadenosine diphosphate-ribose polymerase (PARP) and hexosamine pathways, all increasing oxidative stress, with formation of such reactive oxygen species as the hydroxyl radical, superoxide anion, peroxides, reducing endogenous antioxidants including superoxide dismutase, glutathione, and ascorbic acid and eventuating in oxidative damage of DNA, proteins, and lipids, causing cellular necrosis or apoptosis. 1 Hyperglycemia directly and indirectly increases circulating levels of T cells and macrophages as well as inflammatory and prothrombotic factors, reduces endothelial function, and leads to glycation and oxidation of lipoproteins, increasing their atherogenicity. 1 A specific mediator of oxidative stress involves activation of the transient receptor potential melastatin (TRMP) 2 calcium channel by ischemia/reperfusion injury, a pathway upregulated in diabetes and insulin-resistant states and mediating neuronal cell death in association with oxidative stress. 7 Diabetes leads to reductions in levels of key microRNAs, miRNA-126, miRNA-124, and miRNA-223, which are also downregulated in stroke and which have anti-inflammatory and neuroprotective effects. 8